Global Antidiuretic Drugs Market Overview
Antidiuretic Drugs Market was valued at US$ 558.7 million in 2024 and is projected to grow at a CAGR of 11.5% to reach US$ 1504.8 million by 2034.
Antidiuretic drug helps to balance the fluid in the body. Their action is opposite to which disrupt that of diuretic this balance. Major antidiuretic drugs are desmopressin, vasopression (also called as antidiuretic hormone (ADH)), and oxytoin. In diabetes insipidus, antidiuretic drugs decreases the urine volume. Desmopressin is broadly used antidiuretic drug as it is relatively safe and inexpensive having less adverse reactions to the body. It is primarily used for treating patients with hemophilia.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Antidiuretic Drugs Market Dynamics
Increasing Prevalence of Chronic Disease
The prevalence of chronic conditions that lead to various urologic diseases including polyuria and nocturia, increases with age, and these conditions are prevalent in the geriatric population. The life expectancy of the geriatric population has increased significantly because of rapid developments in healthcare facilities and the availability of advanced treatment options. With the increasing geriatric population and old-age dependency ratio, the incidences of genitourinary conditions will also increase. This will lead to a growing demand for antidiuretic drugs for the treatment of autoimmune and urologic diseases. The rising geriatric population will boost the demand for antidiuretic drugs and drive market growth at a CAGR of almost 11.5% during the forecast period.
Growing usage of desmopressin analogs
The demand for desmopressin analogs is growing from patients and healthcare providers owing to high efficacy of its different formulations. Desmopressin is an artificial form of vasopressin hormone. It avoids dehydration and controls excess urination (polyuria) and increased thirst (polydipsia). Furthermore, the availability of desmopressin analogs in different formulations such as nasal sprays and tablets is further growing its adoption by end-users. The growing usage of desmopressin analogs is recognized as one of the key trends that will gain traction and drive antidiuretic drugs market growth over the forecast period.
Global Antidiuretic Drugs Market Segmentation
The antidiuretic drugs market is segmented based on type, application, and region.
On the basis of type, the global antidiuretic drugs market is segmented into vasopressin, desmopressin, oxytocin, and others. Based on application, the target market is segmented into diabetes insipidus, hemophilia, hypertension, and others.
Regional Insights:
On region the antidiuretic drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America estimated for largest market share due to rising prevalence of diabetes insipidus and increasing demand for new drugs for the treatment of diabetes insipidus. In America, the rate of diabetes insipidus is higher than the rest of the world. As per the data published by International Diabetes Federation in 2016, it was assessed that 420 million adult population was suffering from diabetes which is growing at the rate of 8.4% and is projected to reach 625 million by 2040. Europe is the second highest market that holds a profitable share of the global antidiuretic drugs market. Growing awareness about diabetes insipidus, huge geriatric population suffering from diabetes insipidus and increasing in the risk of developing diabetes insipidus after surgery is boosting growth of the target market in Asia-pacific.
Report Scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 558.7 million |
|
Projected Market Size 2034 |
US$ 1504.8 million |
|
CAGR Growth Rate |
11.5% |
|
Market Segmentation |
By Type- Vasopressin, Desmopressin, Oxytocin, Others
By Application- Diabetes Insipidus, Hemophilia, Hypertension, Others
|
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global Antidiuretic Drugs market report based on test, application, and region:
Antidiuretic Drugs Market, By Type:
- Vasopressin
- Desmopressin
- Oxytocin
- Others
Antidiuretic Drugs Market, By Application:
- Diabetes Insipidus
- Hemophilia
- Hypertension
- Others
Antidiuretic Drugs Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Antidiuretic Drugs Market Key Players
The key players operating the antidiuretic drugs market includes Sanofi, Par Sterile Products LLC, ADH Health, Azevan Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Taj Pharmaceuticals Limited, ALLERGAN, and Bayer. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in February 2020, Sanofi announced to create new industry leading European company to provide active pharmaceutical ingredients (API). New major API company1 would secure significant API manufacturing and supply capacities that are critical for patients in Europe and beyond.
Global Antidiuretic Drugs Market Company Profile
- Sanofi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Par Sterile Products LLC
- ADH Health
- Azevan Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- Otsuka Holdings Co. Ltd.
- Taj Pharmaceuticals Limited
- ALLERGAN
- Bayer
“*” marked represents similar segmentation in other categories in the respective section
Global Antidiuretic Drugs Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings— Outlook for Antidiuretic Drugs Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Antidiuretic Drugs Market, By Type, 2024 – 2034, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Vasopressin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Desmopressin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Oxytocin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Antidiuretic Drugs Market, By Application, 2024 – 2034, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Diabetes Insipidus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Hemophilia
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Hypertension
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Antidiuretic Drugs Market, By Region, 2024 – 2034, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Sanofi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Par Sterile Products LLC
- ADH Health
- Azevan Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- Otsuka Holdings Co. Ltd.
- Taj Pharmaceuticals Limited
- ALLERGAN
- Bayer
- Sanofi
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The antidiuretic drugs market is segmented based on type, application, and region.
the development of novel antidiuretic agents, the focus on personalized medicine for fluid balance disorders, and advancements in drug delivery systems, presenting significant opportunities in the global Antidiuretic Drugs Market.
increasing prevalence of disorders affecting fluid balance, advancements in the understanding of vasopressin physiology, the rising demand for effective antidiuretic therapies, and the development of targeted drugs.
The report typically covers regions worldwide. Domination in the Antidiuretic Drugs Market may vary based on factors such as the prevalence of fluid balance disorders, healthcare infrastructure, and market presence of key players.
The key players operating the global antidiuretic drugs market includes Sanofi, Par Sterile Products LLC, ADH Health, Azevan Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Taj Pharmaceuticals Limited, ALLERGAN, and Bayer.